Is Spark Therapeutics a Bad News Buy?
The company’s latest trial data failed to ignite a rally in its share price.
Saturday, August 18, 2018
Is Spark Therapeutics a Bad News Buy?
Is Spark Therapeutics a Bad News Buy?
The company’s latest trial data failed to ignite a rally in its share price.
Related Posts:
Hundreds of flights canceled as Midwest braces for snowstorm- Campbell Soup nears deal with Third Point to end board challenge: source
- Campbell Soup nears deal with Third Point to end board challenge: sources
- Venezuela settles $1.2 billion creditor claim to protect Citgo
- Asian shares on defensive as plunging oil prices fan growth worries
0 comments:
Post a Comment